The value of biomarkers in clinical decision marking is increasingly recognized, and numerous studies aimed at identifying or validating potential new biomarkers are underway. In this Review, the authors appraise six promising candidate biomarkers, covering diagnosis, disease activity assessment, and prognosis, in order to highlight study design features that are important for biomarker validation.
- Maria G. Tektonidou
- Michael M. Ward
